Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 171 for Prostate cancer

Edit search filters
  1. Focal MR-Guided Focused Ultrasound Treatment Of Localized Intermediate Risk Prostate Lesions

    Rochester, MN

  2. A Study To Evaluate Exercise For Cancer Patients At Risk Of Falling

    Rochester, MN

  3. IS-002 In Prostate Cancer

    Rochester, MN

  4. Understanding The Challenges, Behavioral Patterns, And Preferences Towards Participation In Clinical Trials In Minority Patient Populations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Rochester, MN

  6. A 2 Part, Phase 2 Trial Of Galeterone In The Treatment Of Castration Resistant Prostate Cancer

    Rochester, MN

  7. A Study Of Proton Radiation Divided Into Fewer Doses For Low Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study Of SYNC-T Therapy SV-102 In Participants With Metastatic Castration-Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Hypofractionated Radiation Therapy In Treating Participants With Prostate Cancer High-Risk Features Following Radical Prostatectomy

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Staging Prostate Cancer With Hybrid C11-Choline PET/MR And MpMRI

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer